IMDX — Insight Molecular Diagnostics Share News
0.000.00%
Last trade - 00:00- $92.61m
- $75.62m
- $4.06m
OncoCyte Corp expected to post a loss of 44 cents a share - Earnings Preview
OncoCyte Corp expected to post a loss of 44 cents a share - Earnings Preview
Brief: Oncocyte Files Prospectus Relates To Resale By Selling Stockholders From Time To Time Of Up To 3.5 Million Shares Of Common Stock
Brief: Oncocyte Corp Files For Common Stock Offering Of Up To $7.5 Million- SEC Filing
OncoCyte Corp reports results for the quarter ended in June - Earnings Summary
OncoCyte Corp expected to post a loss of 56 cents a share - Earnings Preview
Brief: OncoCyte Corp Says On July 8, Got Notice From Nasdaq That Co Regained Compliance With Listing Rules
Brief: Oncocyte Appoints Andrea James As Chief Financial Officer
OncoCyte Corp expected to post a loss of 67 cents a share - Earnings Preview
Brief: Oncocyte Files For Resale Of Up To 5.42 Mln Common Shares By Selling Stockholders
OncoCyte Corp expected to post a loss of 67 cents a share - Earnings Preview
Brief: Bio-Rad Laboratories Inc Reports 8.99% Passive Stake In Oncocyte Corp
OncoCyte Corp reports results for the quarter ended in December - Earnings Summary
OncoCyte jumps on partnership with Bio-Rad
Brief: Oncocyte And Bio-Rad Partner On Global Launch Of Transplant Assay
OncoCyte Corp expected to post a loss of $1.14 a share - Earnings Preview
OncoCyte Corp expected to post a loss of $1.14 a share - Earnings Preview
Brief: Oncocyte Begins FDA Submissions Process For Vitagraft Transplant Assays
U.S. RESEARCH ROUNDUP-Apple, Globe Life, Health Catalyst